Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending April 27, 2018. The document serves as a transaction notification regarding insider trading activities involving Persons Discharging Managerial Responsibilities (PDMR) and Persons Closely Associated (PCA) with them.
Key Financial Metrics
The filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. It is strictly a regulatory disclosure of share transactions.
Material Changes
No material changes to the company's financial position or operations are reported in this document. The filing details a specific share transfer event with no change in beneficial ownership.
Transaction Details and Commentary
- Transaction Type: Transfer of Ordinary Shares (ISIN: GB0009252882).
- Parties Involved: Mr. Roger Connor (President, Global Manufacturing & Supply) and his spouse, Mrs. Denise Connor (PCA).
- Volume: 49,152 Ordinary Shares.
- Price: £0.00 (Nil consideration).
- Dates: Transactions occurred on April 26, 2018 (transfer between accounts) and April 27, 2018 (transfer to spouse).
- Nature: The filing explicitly states there was no change in beneficial ownership.
Investor Verification Points
- Verify that the transfer of 49,152 shares between Mr. Connor and his spouse was for nil consideration and did not alter beneficial ownership.
- Confirm the identity of the PDMR (Mr. Roger Connor) and his role as President, Global Manufacturing & Supply.
- Note that this filing contains no operational or financial guidance for the period.